Competition for targets, a tougher stance from regulators and uneven performance are likely to create an uneasy environment for healthcare special purpose acquisition companies in 2022, S&P Global reports. A total of 107 SPACs that listed parts of the healthcare industry as their intended target went public in 2021, according to S&P Global Market Intelligence data. Deal volume picked up in the last four months of the year, with 23 IPOs in November and December. That uptick in volume means more competition for healthcare companies that are mature enough to go public. Read more.
Related Posts
Providers’ Best Weapon Against the ‘Retail Revolution’? Digital Health Transformation
An expert offers perspective on what hospitals and health systems should be doing to hold their own against competitors such as Amazon, CVS, Walgreens and Walmart.
May 17, 2022
BRG 2Q Healthcare M&A Update
Deal volume in the home health and hospice sector decreased ~30% year over year, with a 19% decrease quarter over quarter (Q2 ‘22 vs. Q2 ’23). This decrease is primarily attributable to uncertainty of reimbursement rate cuts and interest rate increases.
August 22, 2023
Why 2022 Will be the Year of M&A for Digital Mental Health
There have already been a few game-changing acquisitions in the space — the earliest and most defining is the merger of Ginger and Headspace, which created a $3 billion company.
February 23, 2022
PE Continues to Snatch up Healthcare Services Companies for Roll-Up Plays
Looking ahead, cash-rich PE investors are expected to continue to pump money into the healthcare services industry, which is typically considered more recession-resistant.
November 29, 2022